[Federal Register: February 25, 1999 (Volume 64, Number 37)]
[Notices]               
[Page 9343-9344]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr25fe99-78]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

 
National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of 
the Board of Scientific Counselors, National Cancer Institute.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with 
provision set forth in sections 552b(c)(6), Title 5 U.S.C., as amended 
for the review, discussion, and evaluation of individual intramural 
programs and projects conducted by the National Cancer Institute, 
including consideration of personnel qualifications and performance, 
and the competence of individual investigators, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Board of Scientific Counselors, National 
Cancer Institute, Subcommittee B--Basic Sciences.
    Date: March 8, 1999.
    Open: March 8, 1999, 8:00 am to 10:15 am.
    Agenda: Joint Session with Board of Scientific Advisors, 
National Cancer Institute, Report of the Director, NCL.
    Place: National Cancer Institute, 9000 Rockville Pike, Building 
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
    Closed: March 8, 1999, 10:30 am to 11:30 am, Joint Meeting of 
the Board of Scientific Counselors, National Cancer, Institute, 
Subcommittee A--Clinical Sciences and Epidemiology and Subcommittee 
B--Basic Sciences.
    Agenda: To Review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Cancer Institute, 9000 Rockville Pike, Building 
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
    Closed: March 8, 1999, 12:00 pm to 5: pm, Board of Scientific 
Counselors, National Cancer Institute, Subcommittee B--Basic 
Sciences.
    Agenda: To Review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: The Hyatt Regency, Chesapeake Suites, One Bethesda Metro 
Center, Bethesda, MD 20814.
    Contact Person: Florence E. Farber, Ph.D., Executive Secretary, 
Office of Advisory Activities, Division of Extramural Activities, 
National Cancer Institute, National Institutes of Health, 6130 
Executive Boulevard, EPN 609, Rockville, MD 20892, (301) 496-2378.
    Name of Committee: Board of Scientific Counselors, National 
Cancer Institute, Subcommittee A--Clinical Sciences and 
Epidemiology.
    Date: March 8-9, 1999.
    Closed: March 8, 1999, 10:30 am to 11:30 am, Joint Meeting of 
the Board of Scientific Counselors, National Cancer Institute, 
Subcommittee A--Clinical Sciences and Epidemiology and Subcommittee 
B--Basic Sciences.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.

[[Page 9344]]

    Place: National Cancer Institute, 9000 Rockville Pike, Building 
31, C Wing, 6th Floor, Conference Room 6, Bethesda, MD 20892.
    Closed: March 8, 1999, 11:30 am to 5:00 pm.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: Building 31, C Wing, 6th Floor, Conference Room 6, 
National Institutes of Health, 3100 Center Drive, Bethesda, MD 
20892.
    Closed: March 9, 1999, 8:30 am to 12:30 pm, Board of Scientific 
Counselors, National Cancer Institute, Subcommittee A--Clinical 
Sciences and Epidemiology.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Cancer Institute, 9000 Rockville Pike, Building 
31, C Wing, 6th Floor, Conference Room 6, Bethesda, MD 20892.
    Contact Person: Judy Meitz, Ph.D., Executive Secretary, Office 
of Advisory Activities, Division of Extramural Activities, National 
Cancer Institute, National Institutes of Health, 6130 Executive 
Boulevard, EPN 609, Rockville, MD 20892-7410, (301) 496-2378.
    This notice is being published less than 15 days prior to the 
meeting due to the urgent need to meet timing limitations imposed by 
the intramural research review cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: February 18, 1999.
Anna Snouffer,
Acting Committee Management Officer, NIH.
[FR Doc. 99-4654 Filed 2-24-99; 8:45 am]
BILLING CODE 4140-01-M